Anbio Biotechnology Cl A (NNNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NNNN | ADMA | ACAD | ||
| Company | Anbio Biotechnology Cl A | Adma Biologics | Acadia Pharmaceutica | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 30.75 | 18.80 | 26.81 | ||
| High | 32.35 | 19.68 | 27.51 | ||
| Low | 29.00 | 18.80 | 26.56 | ||
| Latest | 32.35 | 19.58 | 27.16 | ||
| Change | +2.10 | +0.77 | +0.56 | ||
| % Change | +6.94% | +4.09% | +2.11% | ||
| Volume | 7,500 | 4,654,500 | 3,363,800 | ||
| 20-Day Average Volume | 29,985 | 3,004,940 | 1,578,945 | ||
| Previous Close | 30.25 | 18.81 | 26.60 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 29.77 | 19.34 | 26.04 | ||
| 20-Day Raw Stochastic | 49.94% | 78.88% | 88.43% | ||
| 20-Day Relative Strength | 53.96 | 60.72 | 63.83 | ||
| Weighted Alpha | +4.50 | +16.75 | +56.25 | ||
| Today's Opinion | 40% Buy | 56% Buy | 88% Buy | ||
| Previous Opinion | 24% Buy | 40% Buy | 88% Buy | ||
| Last Month's Opinion | 40% Sell | 40% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.94% since 12/12/25 | -1.01% since 12/12/25 | +0.04% since 12/12/25 | ||
| Low | 26.06 on 12/15/25 | 18.33 on 12/16/25 | 26.56 on 12/19/25 | ||
| High | 36.12 on 12/18/25 | 19.97 on 12/15/25 | 27.51 on 12/19/25 | ||
| 1-Month | |||||
| %Chg | +17.34% since 11/19/25 | +22.76% since 11/19/25 | +17.58% since 11/19/25 | ||
| Low | 20.00 on 11/24/25 | 16.23 on 11/20/25 | 22.81 on 11/20/25 | ||
| High | 44.73 on 12/05/25 | 20.46 on 12/12/25 | 27.73 on 12/08/25 | ||
| 3-Month | |||||
| %Chg | -24.04% since 09/19/25 | +23.07% since 09/19/25 | +11.22% since 09/19/25 | ||
| Low | 10.50 on 11/04/25 | 13.76 on 11/07/25 | 19.69 on 10/13/25 | ||
| High | 51.33 on 10/03/25 | 20.46 on 12/12/25 | 27.73 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +179.84% since 06/18/25 | +8.00% since 06/18/25 | +18.34% since 06/18/25 | ||
| Low | 10.50 on 11/04/25 | 13.76 on 11/07/25 | 19.69 on 10/13/25 | ||
| High | 55.65 on 07/15/25 | 20.46 on 12/12/25 | 27.73 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,654,874 | 4,660,001 | 4,594,983 | ||
| Shares Outstanding, K | 143,891 | 237,998 | 169,182 | ||
| Annual Sales | 8,185,146 | 426,450,000 | 957,800,000 | ||
| Annual Net Income | 2,372,842 | 197,670,000 | 226,450,000 | ||
| Last Quarter Sales | N/A | 134,220,000 | 278,630,000 | ||
| Last Quarter Net Income | N/A | 36,430,000 | 71,780,000 | ||
| 60-Month Beta | N/A | 0.43 | 0.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.16 on 11/05/25 | 0.26 on 11/05/25 | ||
| Latest Earnings Date | 01/01/70 | 03/02/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 33.19 | 38.80 | ||